Drzezga A - Search Results

1

Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study.

Grimmer T, Diehl J, Drzezga A, Förstl H, Kurz A. Grimmer T, et al. Among authors: drzezga a. Dement Geriatr Cogn Disord. 2004;18(1):32-6. doi: 10.1159/000077732. Epub 2004 Apr 6. Dement Geriatr Cogn Disord. 2004. PMID: 15084791 Clinical Trial.

2

Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia.

Arnold S, Berthele A, Drzezga A, Tölle TR, Weis S, Werhahn KJ, Henkel A, Yousry TA, Winkler PA, Bartenstein P, Noachtar S. Arnold S, et al. Among authors: drzezga a. Epilepsia. 2000 Jul;41(7):818-24. doi: 10.1111/j.1528-1157.2000.tb00248.x. Epilepsia. 2000. PMID: 10897152 Free article.

3

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF. Lautenschlager NT, et al. Among authors: drzezga a. Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):379-86. doi: 10.1159/000051284. Dement Geriatr Cogn Disord. 2001. PMID: 11598309

4

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, Förstl H, Kurz A. Riemenschneider M, et al. Among authors: drzezga a. Neurology. 2002 Jun 11;58(11):1622-8. doi: 10.1212/wnl.58.11.1622. Neurology. 2002. PMID: 12058089

5

Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia.

Drzezga A, Grimmer T, Siebner H, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. J Neurol. 2002 Sep;249(9):1263-7. doi: 10.1007/s00415-002-0832-z. J Neurol. 2002. PMID: 12242551

6

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A. Riemenschneider M, et al. Among authors: drzezga a. Arch Neurol. 2002 Nov;59(11):1729-34. doi: 10.1001/archneur.59.11.1729. Arch Neurol. 2002. PMID: 12433260

7

The role of biological markers in the early and differential diagnosis of Alzheimer's disease.

Kurz A, Riemenschneider M, Drzezga A, Lautenschlager N. Kurz A, et al. Among authors: drzezga a. J Neural Transm Suppl. 2002;(62):127-33. doi: 10.1007/978-3-7091-6139-5_13. J Neural Transm Suppl. 2002. PMID: 12456058 Review.

8

PET in patients with clear-cut multiple chemical sensitivity (MCS).

Bornschein S, Hausteiner C, Drzezga A, Bartenstein P, Schwaiger M, Förstl H, Zilker T. Bornschein S, et al. Among authors: drzezga a. Nuklearmedizin. 2002 Dec;41(6):233-9. Nuklearmedizin. 2002. PMID: 12520659

9

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12764551 Clinical Trial.

10

Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.

Diehl J, Grimmer T, Drzezga A, Riemenschneider M, Förstl H, Kurz A. Diehl J, et al. Among authors: drzezga a. Neurobiol Aging. 2004 Sep;25(8):1051-6. doi: 10.1016/j.neurobiolaging.2003.10.007. Neurobiol Aging. 2004. PMID: 15212830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters